儿童重症支原体感染诊治相关问题.pdf

儿童重症支原体肺炎诊治相关问题

2023年11月10日

TABLE1ClinicalinformationofMRandMSpatients

P

ClinicalinformationMSgroup(n=29)

MRgroup(n=206)

Medianageinyrs(range)4(0-14)5(0-11)NS?

No.ofpatients(male/female)132/7417/12NS

96PatientsWithsevereMPP18.4(38/206)3.4(1/29)0.042

8

tientswithlargelesionsonchestradiography重症比例

61.7(127/206)41.3(12/29)0.038

Mediandurationsindays(range)

大片实变

Feverduration8(0-42)6(0-14)0.001

Hospitalizationduration8(2-45)6(3-16)0.007

5(0-42)3(0-10)0.007

Feverdurationaftermacrolidetherapy

29.6(61/206)10.3(3/29)0.029

86Patientsprescntingwithextrapulmonarycomplications

肺外并发

44.3(27/61)100(3/3)

Digestivesystem(liverfunctionabnormalities)

症比例24.6(15/61)0(0/3)

Cardiovascularsystem(myocarditis)

Rash18.0(11/61)0(0/3)

Nervoussystem(encephalitis)6.6(4/61)0(0/3)

Urinarysystem(proteinuria)3.3(2/61)0(0/3)

Hematologicsystem(hemolyticanemia)0(0/3)

1.6(1/61)

Jointsystem(arthritis)1.6(1/61)0(0/3)

Ns.notsigntficant.

AntimicrobAgentsChemother.2014;58(2):1034-8.

重症难治性支原体感染(RMPP)的诊断

韩国日本